AVE 33.3% 0.2¢ avecho biotechnology limited

oxymorphone patch m eets phase 1 end points, page-22

  1. 8,604 Posts.
    lightbulb Created with Sketch. 83
    ..I think the only short term driver mak, would be news of oxyc trials beginning..otherwise it's the same old.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.